ABBV: AbbVie Inc. Stock

by  •  • Comments Off on ABBV: AbbVie Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 341,610.88
Enterprise Value ($M) 399,464.88
Book Value ($M) 8,047.00
Book Value / Share 4.56
Price / Book 42.45
NCAV ($M) -101,300.00
NCAV / Share -57.35
Price / NCAV -3.37

Profitability (mra)
Return on Invested Capital (ROIC) 0.07
Return on Assets (ROA) 0.04
Return on Equity (ROE) 0.40

Liquidity (mrq)
Quick Ratio 0.71
Current Ratio 0.81

Balance Sheet (mrq) ($M)
Current Assets 33,816.00
Assets 141,937.00
Liabilities 135,116.00
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 54,318.00
Operating Income 17,425.00
Net Income 4,863.00
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 22,839.00
Cash from Investing -2,009.00
Cash from Financing -17,222.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-13 13G/A Vanguard Group Inc 9.08 1.30
01-25 13G/A BlackRock Inc. 8.10 3.23

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-02-20 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 10-K (MARK ONE) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
2023-11-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-09-09 533,825 2,432,595 21.94
2024-09-06 501,676 3,057,736 16.41
2024-09-05 603,963 4,085,163 14.78
2024-09-04 355,327 2,704,783 13.14

(click for more detail)

Similar Companies
ABT – Abbott Laboratories ADCT – ADC Therapeutics SA


Financial data and stock pages provided by
Fintel.io

Finpedia: AbbVie Inc.